50
Participants
Start Date
January 9, 2023
Primary Completion Date
October 30, 2025
Study Completion Date
December 31, 2025
Xanthohumol
Patients, who received Xanthohumol (Chmiel-Xn-Active, SALUTIS Pharmacy, Poland) as adjunctive therapy to treatment recommended by Surviving Sepsis Campaign. Xanthohumol is administrated by the nosogastric tube three times a day \*every 8 hours) at the dose of 2 mg.\\/kg body weight for 10 days. The first dose of Xanthohumol is administrated within 4 hours after the admission to the ICU.
RECRUITING
Intensive Care Unit, University Hospital No 4,, Lublin
Medical University of Lublin
OTHER